Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Showing 41 to 44 of 44

TitleReference numberPublishedLast updated
Panobinostat for treating multiple myeloma after at least 2 previous treatmentsTA380
Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantationTA311
Bortezomib and thalidomide for the first‑line treatment of multiple myelomaTA228
Bortezomib monotherapy for relapsed multiple myelomaTA129

Results per page

  1. 10
  2. 25
  3. 50
  4. All